tadocizumab

tadocizumab Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Treatment of patients undergoing percutaneous coronary interventions.

tadocizumab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

tadocizumab Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Shanghai YuanYe Biotechnology Co., Ltd.	021-61312847; 18021002903	3008007409@qq.com	China	71826	60
ShangHai Biochempartner Co.,Ltd	177-54423994 17754423994	2853530910@QQ.com	China	8000	62
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10308	58
TargetMol Chemicals Inc.	4008200310	marketing@tsbiochem.com	China	24961	58
Biolab Reagents	027-65279366 18108604356	products@biolabreagent.com	China	9868	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 086-15871494362 13720134139	orders@jknbiochem.com	China	6762	58
Shanghai Yifei Biotechnology Co. , Ltd.	021-65675885 18964387627	customer_service@efebio.com	China	11973	58
Changsha Fuzhen Biotechnology Co.，LTD	0731-13823398 15111215862	313359644@qq.com	China	4161	58
Olix (Shanghai) Pharmaceutical Technology Co., Ltd	17316404525 17316404525	209533805@qq.com	China	9763	58
Atagenix Laboratories	027-87008169 17762441161	info@atagenix.com	China	10001	58

---

• tadocizumab
• Research Grade Tadocizumab (DHC33303)
• Research Grade Tadocizumab
• Tadocizumab (anti-Integrin α2β3)
• 339086-80-5